Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
Catheter ablation (CA) of atrial fibrillation and flutter is associated with a high risk of both perioperative thromboembolic events and bleeding. Adequate anticoagulation is imperative to reduce the risk of complications. The aim of this review was to analyze modern approaches to anticoagulant ther...
Saved in:
| Main Authors: | M. V. Serova, D. A. Andreev, M. I. Chashkina, Z. K. Salpagarova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2021-09-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2974 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Temporal trends of catheter ablation procedures in patients with atrial fibrillation and atrial flutter: A nationwide cohort study
by: Antti Lappalainen, et al.
Published: (2024-12-01) -
Assessment of Long‐Term Use Versus Discontinuation of Direct Oral Anticoagulant After Catheter Ablation for Atrial Fibrillation—RYOUMA Registry Subanalysis
by: Yuka Oda, et al.
Published: (2025-05-01) -
Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation
by: M. A. Zelberg, et al.
Published: (2024-05-01) -
POSSIBILITY OF NOVEL ORAL ANTICOAGULANTS USAGE DURING ABLATION IN ATRIAL FIBRILLATION
by: B. A. Tatarsky, et al.
Published: (2014-12-01) -
Care for Atrial Fibrillation and Outcomes in Rural Versus Urban Communities in the United States: A Systematic and Narrative Review
by: Anthony L. Lin, et al.
Published: (2025-03-01)